Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Sheng-Xian Wu"'
Autor:
Ying Zhao, Yuan-Yuan Yang, Bao-Lin Yang, Ya-Wei Du, Da-Wei Ren, Hong-Mei Zhou, Jing Wang, Hui-Min Yang, Yao-Xian Wang, Ying-Ying Zhang, Sheng-Xian Wu
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-8 (2021)
Abstract Background Dyslipidemia is a major risk factor for atherosclerotic cardiovascular disease and a leading cause of death worldwide. The clinical utility of commonly used lipid-lowering drugs such as statins and fibrates is sometimes limited by
Externí odkaz:
https://doaj.org/article/248185d0c74a4a1d9763528878e41183
Autor:
Ying Zhao, Le Sun, Chongming Wu, Ying-Ying Zhang, Baoli Zhu, Yanan Yang, Peng Guo, Fang Zhang, Yuan-Yuan Yang, Wenquan Su, Jiaqi Yu, Sheng-Xian Wu, Yao-Xian Wang
Publikováno v:
Journal of Advanced Research. 37:197-208
Introduction Gut microbiota has been implicated in the pharmacological activities of many natural products. As an effective hypolipidemic agent, berberine (BBR)’s clinical application is greatly impeded by the obvious inter-individual response vari
Autor:
Ri-Na, Sha, Lu, Tang, Ya-Wei, Du, Sheng-Xian, Wu, Hua-Wei, Shi, Hong-Xin, Zou, Xu-Ran, Zhang, Xing-Lu, Dong, Li, Zhou
Publikováno v:
J Tradit Chin Med
OBJECTIVE: To evaluate the effectiveness and safety of Ginkgo biloba extract (GBE50) in the treatment of dizziness caused by cerebral arteriosclerosis. METHODS: This was a multi-center, double-blind, double-dummy, positive -controlled, parallel rando
Autor:
Ke-han Sun, Man-fang Yang, Xin-rui Xu, Yang Li, Zhao Gao, Qing-yue Zhang, Hui Li, Shu-qi Wang, Li-xia Lou, Ai-ming Wu, Qiu-shuo Jin, Sheng-xian Wu, Bo Nie
Publikováno v:
Evidence-based complementary and alternative medicine : eCAM. 2022
Simiao Yong’an decoction (SMYAD), a classic traditional Chinese medicine formula, has been used to treat atherosclerosis (AS) in clinical in China, but its therapeutic mechanism and pharmacodynamic material basis are not clear. In this study, the A
Autor:
Jiaqi Yu, Ya-Nan Yang, Wenquan Su, Sheng-Xian Wu, Fang Zhang, Chaoran Dong, Qinhua Fan, Chongming Wu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 139, Iss, Pp 111595-(2021)
Background Akkermansia spp. plays important roles in maintenance of host health. Increasing evidence reveals that berberine (BBR) may exert its pharmacological effects via, at least partially, promotion of Akkermansia spp. However, how BBR stimulates
Publikováno v:
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 45(3)
To evaluate the clinical efficacy and safety of berberine in the treatment of dyslipidemia. In this review, CNKI, WanFang, VIP, CBM, PubMed, Cochrane Library, EMbase, and Medline(OVID) were retrieved from database establishment to January, 2019 in an
Autor:
Du Yawei, Lifang Xie, Fang He, Rongrong Wu, Wenquan Su, He Li, Sheng-Xian Wu, Lixia Lou, Aiming Wu
Publikováno v:
Journal of Thermal Biology. 99:102972
Background Several lines of evidence indicate that cold stimulation may not only activate brown adipose tissue (BAT) and the white adipose tissue (WAT), but also regulate the lipid metabolism and influence the development of atherosclerosis. However,
Publikováno v:
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 43(15)
The post-marketing re-evaluation of traditional Chinese medicine (TCM) is a crucial stage for drug evaluation. Due to the particularity of TCM, it is necessary to re-evaluate the effectiveness of certain Chinese medicines by studying and collecting t
Autor:
Zhen-Yu Dong, Sheng-Xian Wu
Publikováno v:
Current Vascular Pharmacology. 13:504-519
Objective There are more than 300 million patients with hypertension in China, and at least 1 in 5 is using or has ever used Chinese Medicine (CM) treatment. Scope This article reviews the efficacy and safety of CM as monotherapy and in combination w